John Bucuvalas, MD Email John Bucuvalas
- PROFESSOR | Pediatrics, Hepatology
- Pediatric Hepatology
- Liver Transplantation
- Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
- RMTI Pediatric Liver Disease and Transplantation 212-659-8060 212-659-8060
John Bucuvalas, MD is the Chief of the Division of Hepatology and Vice Chair of Faculty Affairs in the Jack and Lucy Clark Department of Pediatrics at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Kravis Children's Hospital. He also serves as the Director of Solid Organ Transplant Outreach for the Recananti- Miller Transplant Institute. He graduated from Harvard College, Magna Cum Laude in biology and then obtained his medical degree at Harvard Medical School. He completed his pediatric residency including a year as Chief Resident before his gastroenterology fellowship at Cincinnati Children’s Hospital. He is board certified in pediatric gastroenterology with a certificate of added qualification in transplant hepatology. He advanced to Professor of Pediatrics at the University of Cincinnati and served as Director of the Integrated Solid Organ Transplant Program before coming to Mount Sinai Hospital.
CLINICAL: Dr. Bucuvalas’ primary clinical focus is transplant hepatology, recognized by the American Board of Internal Medicine and American Board of Pediatric as a discipline with distinct body of knowledge by a certificate of adequate qualification. He serves as the attending physician on the inpatient liver service and care for outpatients with acute and chronic liver disease.
PERSONAL STATEMENT: My goal is for children with liver disease to live full, meaningful lives. I have been fortunate to experience and be part of the tremendous innovations in care for children with complex and serious liver disease. When I started my career, children with serious liver disease had few options and many died before the age of 5 years. Now, we have medical and surgical treatments including liver transplantation that have revolutionized our approach. Along the way, I established collaborations and relationships with clinical and research leaders both inside and outside the United States. I have been equally fortunate with the opportunity to integrate these efforts with learnings from other industries. In 2002, I underwent training in improvement science, which, in turn, combined with my traditional research training gave me the tools to meet my goal. Through learning from patient and family experience and collaborations with colleagues outside of medicine at MIT, Harvard Business School and with urban architects, I gained a better understanding of how we can use privacy, transparency, team effectiveness, communication and decision-making to make care better. Throughout my career, I have better recognized the value of diverse expertise, and it helped to guide my approach towards care and research.
American Board of Pediatrics
- Acute and Chronic Liver Failure
- Biliary Atresia
- Chronic Liver Disease
- Liver Failure/Liver Transplantation
- Metabolic Liver Disease
MD, Harvard Medical School
Massachusetts General Hospital
Cincinnati Childrens Hospital
Castle Connolly Regional Top Doctor 2015 - present
Chair in Transplant Hepatology, Cincinnati Children’s Hospital
Invited Speaker as Visiting Professor at National Society Meetings
Member, American Pediatric Society
Fellow, American Association for the Study of Liver Disease
Dr. Bucuvalas’ research focus aligns with on challenges faced by children and adolescent who seek and undergo the life-saving intervention of liver transplantation. His research efforts have driven by the challenges along the path of the patient to sustained heath including but not limited to wait list management, mitigation of complications, and ensuring long-term allograft health without complications of immunosuppression.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Bucuvalas did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.